Takeda Pharmaceutical
298 hedge funds and large institutions have $1.04B invested in Takeda Pharmaceutical in 2021 Q4 according to their latest regulatory filings, with 61 funds opening new positions, 65 increasing their positions, 105 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1% less ownership
Funds ownership: 5.81% → 4.81% (-1%)
31% less capital invested
Capital invested by funds: $1.51B → $1.04B (-$465M)
38% less repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 105
Holders
298
Holding in Top 10
3
Calls
$60.1M
Puts
$11.9M
Top Buyers
| 1 | +$69M | |
| 2 | +$65.6M | |
| 3 | +$16.8M | |
| 4 |
HT
HAP Trading
New York
|
+$9.4M |
| 5 |
BlackRock
New York
|
+$5.12M |
Top Sellers
| 1 | -$133M | |
| 2 | -$90.4M | |
| 3 | -$79.1M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$21.3M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$18.5M |